Columbia University Cystic Fibrosis Program — New York, New York

Columbia University Cystic Fibrosis Program is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Columbia University Cystic Fibrosis Program has participated in 7 clinical trials with 4 currently active.

Therapeutic areas: Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes, Diabetes.

Sponsors: Jaeb Center for Health Research, Respirion Pharmaceuticals Pty Ltd, Nicole Hamblett.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University Cystic Fibrosis Program?

Columbia University Cystic Fibrosis Program has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University Cystic Fibrosis Program conducted?

Columbia University Cystic Fibrosis Program has 7 clinical trials on record, with 4 currently active. Their work covers Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes, Diabetes.

Is Columbia University Cystic Fibrosis Program accredited by Crixeo Health?

Yes — Columbia University Cystic Fibrosis Program holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Columbia University Cystic Fibrosis Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.